TY  - JOUR
AU  - Salido-Vallejo, Rafael
AU  - Escribano-Castillo, Lourdes
AU  - Antoñanzas, Javier
AU  - Roldán-Córdoba, Claudia
AU  - Velez Garcia-Nieto, Antonio
AU  - Aguado-Gil, Leyre
PY  - 2023
DO  - 10.3390/jcm12247619
SN  - 2077-0383
UR  - https://hdl.handle.net/10668/23202
T2  - Journal of Clinical Medicine
AB  - Introduction: Cutaneous squamous cell carcinoma (cSCC) is the second most common cutaneous neoplasm, and its incidence is on the rise. While most cSCCs have an excellent prognosis, certain risk factors, especially immunosuppression, have been...
LA  - en
PB  - MDPI
KW  - Immunosuppression
KW  - Immunocompromised
KW  - Solid organ transplant
KW  - Cutaneous squamous cell carcinoma
KW  - Prognosis
KW  - Recurrence; metastasis
KW  - Non-melanoma skin cancer
KW  - Inmunosupresión
KW  - Inmunocomprometidos
KW  - Trasplante de órganos sólidos
KW  - Escamoso cutáneo carcinoma de células
KW  - Pronóstico
KW  - Cáncer de piel no melanoma
KW  - Reaparición
KW  - Metástasis
KW  - Humans
KW  - Carcinoma, Squamous cell
KW  - Skin Neoplasms
KW  - Prognosis
KW  - Follow-up studies
KW  - Incidence
KW  - Progression-free survival
KW  - Spain
KW  - Organ transplantation
KW  - Immunosuppression therapy
KW  - Risk factors
KW  - Risk assessment
KW  - Hospitals
KW  - Observational studies as topic
TI  - Prognostic Outcomes of Cutaneous Squamous Cell Carcinoma in Solid Organ Transplant Recipients: A Retrospective Comparative Cohort Study
TY  - research article
VL  - Dec 11;12
ER  -